Pear Therapeutics Inc - Ordinary Shares - Class A

NASDAQ:PEAR   1:21:23 PM EDT
1.99
+0.04 (+2.05%)
Layoffs, Earnings Announcements

Pear Therapeutics Says Board Approved Reduction In Workforce By About 59 Employees, Representing About 22% Of Co's Total Workforce As Of Sept 30, 2022

Published: 11/14/2022 21:53 GMT
Pear Therapeutics Inc - Ordinary Shares - Class A (PEAR) - Pear Therapeutics- Board Approved Reduction in Workforce by About 59 Employees, Representing About 22% of Co's Total Workforce As of Sept 30, 2022.
Pear Therapeutics Inc- Reduction in Workforce is Intended to Reduce Operating Expenses.
Pear Therapeutics- Estimates Will Incur About $2.6 Million of Cash Based Expenses Related to Employee Severance, Benefits, Related Costs, Primarily in Q4 2022.
Further Company Coverage: Pearo ((reuters.
Briefs@thomsonreuters.
Com;)).
Revenue is expected to be $4.79 Million
Adjusted EPS is expected to be -$0.22

Next Quarter Revenue Guidance is expected to be $5.75 Million
Next Quarter EPS Guidance is expected to be -$0.15

More details on our Analysts Page.